SS
Serge Saxonov (Chief Executive Officer) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in 10x Genomics, Inc. (TXG). The largest single filing was $2.0M of TXG (24,000 sh across 4 lots, as filed), executed Sep 22. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
10
0 buys · 10 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.3M
shares × price, as filed
Last traded
Sep 22
Filed Sep 24
Median ADV $190.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
TXGRecent filings
TXGSALE
10x Genomics, Inc.
View filing →
$2.0M24,000 sh across 4 lots
Exec Sep 22
Filed Sep 24 · 4:29 PM ET TXGSALE 10x Genomics, Inc. View filing → $636K
9,994 sh across 2 lots
Exec Aug 26
Filed Aug 28 · 7:22 PM ET TXGSALE 10x Genomics, Inc. View filing → $1.2M
18,545 sh × $63.02
Exec Aug 24
Filed Aug 26 · 4:46 PM ET TXGSALE 10x Genomics, Inc. View filing → $973K
28,339 sh across 3 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET TXGSALE 10x Genomics, Inc. View filing → $709K
28,893 sh across 2 lots
Exec May 22
Filed May 27 · 5:30 PM ET TXGSALE 10x Genomics, Inc. View filing → $123K
5,000 sh × $24.56
Exec Apr 14
Filed Apr 16 · 5:30 PM ET TXGSALE 10x Genomics, Inc. View filing → $191K
10,000 sh × $19.13
Exec Mar 23
Filed Mar 25 · 5:30 PM ET TXGSALE 10x Genomics, Inc. View filing → $324K
14,292 sh × $22.67
Exec Mar 2
Filed Mar 4 · 5:30 PM ET More filings →